江蘇恒瑞醫(yī)藥簡介 PPT

1、 Jiangsu Hengrui Medicine Co., Ltd江蘇恒瑞醫(yī)藥股份有限公司江蘇恒瑞醫(yī)藥股份有限公司2006 Better medicines to peoples health 關(guān)愛人類健康關(guān)愛人類健康 Jiangsu Hengrui Medicine Co., IntroductionJiangsu Hengrui MedicinenEstablished: 1970 nHead Office: Lianyungang ,Jiangsu, ChinanPresident: Mr.Piaoyang SunnEmployees : 1800nincluding: R&D

2、 230 恒瑞醫(yī)藥始建于1970年，公司位于江蘇連云港 董事長 孫飄揚 公司現(xiàn)有員工2000人，研發(fā)人員230人Main Businesses LineHengrui mainly produces antineoplastics,cardiovascular, analgesic, antibiotics .Hengrui was the No. 1 Antineoplastic sales in China Market in 2003、2004. 恒瑞主要從事抗腫瘤藥、心血管類藥、鎮(zhèn)痛類藥、抗生素的生產(chǎn)。 2003、2004年抗腫瘤藥銷量全國排名第一。Hengrui GroupnJian

3、gsu Hengrui Medicine Co., Ltd. Pharmaceuticals and R&DnShanghai Hengrui Medicine Co., Ltd. Pharmaceuticals and R&D 成都成都上海上海 連云港Workshop & Equipment Hengrui has two factory zones, the old one is located at Xinpu, the new one is located at ECO. & TECH Development Zone. 恒瑞現(xiàn)有兩個廠區(qū)：新浦廠區(qū) 開發(fā)

4、區(qū)新廠區(qū)Workshop & Equipment The Xinpu factory is the main area of synthesizing and producing bulk drugs, including two solid preparation which passed to GMP inspection and 6 bulk drugs workshops. It can produce 20 kinds of chemical medicines 1.6 billion pills, 50 tons of 40 kinds of bulk drugs per

5、year. 新浦廠區(qū)主要是固體制劑與原料藥生產(chǎn)地，擁有2個通過 GMP認證的固體制劑車間、6個原料車間。 年生產(chǎn)能力為西藥20種16億片，化學(xué)原料藥40種50噸。Head officeWorkshop & EquipmentGMP固體制劑車間 Solid Preparation Workshop & EquipmentThe new factory has an area of 30 thousand of square meters, which built preparation workshops according to GMP, and imported a batc

6、h of advanced equipment and production line. Now the factory is capable of producing 50 million injections, 2 million lyophilized powders and 2 million sterile split charging powder. 開發(fā)區(qū)新廠區(qū)占地3萬多平方米，新建了符合GMP要求的制劑車間，并已引進了一批國外的先進設(shè)備儀器，新增年產(chǎn)針劑5000萬支、凍干粉針200萬瓶、滅菌分裝粉針200萬瓶的生產(chǎn)能力。 Capacity of Jiangsu Hengrui5

7、0 million injections, 2 million lyophilized powders 2 million sterile split charging powder. 500 million troches12 million transfusion bags Freeze Dryer Imported from EDWARDSForm-Fill-Seal LineSolid Preparation Auto-Line Auto-Packing Line 上海分公司上海分公司2004年上半年建成投產(chǎn)。年上半年建成投產(chǎn)。Shanghai Hengrui was in produ

8、ction in Jun. 2004 Subsidiary company Shanghai HengruiShanghai Hengrui CampusSales NetSale network covers all of the country.There are 62 sale offices inside China.Salespersons are over 1300.Active Pharmaceutical ingredients are mainly sold to USA and Europe.,恒瑞有九個銷售公司，在全國各地有80個辦事處，共有1500名銷售代表Jinags

9、u Hengrui Sales Status Top 5 Products in 2004 2001 2001年恒瑞醫(yī)藥年恒瑞醫(yī)藥原料藥異環(huán)磷酰胺、足葉乙甙、美司那、噻原料藥異環(huán)磷酰胺、足葉乙甙、美司那、噻替派通過了美國替派通過了美國FDAFDA驗證。驗證。 Ifosfamide, Ifosfamide, EtoposideEtoposide, , MesnaMesna and and ThiotepaThiotepa were were approved by FDA in 2001.approved by FDA in 2001.FDA ApprovingExport Status Of

10、Raw Chemical MaterialUnit: ￥Ten thousand(RMB)R &D Activity 研究與開發(fā)研究與開發(fā)恒恒瑞擁有瑞擁有2個研究中心個研究中心 Hengrui Has Two R&D Centers恒瑞恒瑞連云港研究中心連云港研究中心 Lianyungang R&D Center 人員Researcher and Engineer：130 Persons 化學(xué)合成、植物藥、中試研究、通用名藥物 Chemical Synthesizing, Plant Drugs, Scale Test Before Production, Generi

11、c Medicines恒恒瑞瑞上海研究中心上海研究中心 Shnaghai R&D Center 人員Researcher and Engineer：60 Persons 藥物設(shè)計、化學(xué)合成、制劑研究、生物工程 Drug Design ,Chemical Synthesizing, Preparation Improvement, Biology EngineeringR & D Activity 研究研究化學(xué)藥物化學(xué)藥物 Chemical Medicine:COX-2抑制劑抑制劑 Inhibitor BNP909 in Phase I BNP811 in Preclinical

12、糖尿病PPAR激動劑 Diabetes PPARAgonist抗腫瘤藥物 Antineoplastics胃動力藥 Gastrokinetic agents抗生素 Antibiotics R & D Activity 研究研究植物藥植物藥 Plant Drugs肝病治療藥肝病治療藥Liver Treatment Drugs鎮(zhèn)咳藥鎮(zhèn)咳藥 Antitussivers婦科用藥婦科用藥 Gynecological Drugs生物工程生物工程 Biology Engineering單克隆抗體單克隆抗體 Monoclonal Antibody多肽合成多肽合成 Polypeptide Synthesis合作研究合作研究 R&D Cooperation與美國與美國ChironChiron公司合作研究公司合作研究 Cooperation Development with Chiron in USA : Cooperation Development with Chiron i